Fact CheckerSign in

NCT07109141Recruiting

Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland

Source: ClinicalTrials.gov · Last updated 7 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of the described project is to establish a multicenter, nationwide registry of atrial arrhythmia ablation procedures using the Pulsed Field Ablation (PFA) method. These procedures have only recently begun to be performed in several centers across Poland. With proper coordination of the registry, this will enable the consolidation of clinical data and the expansion of knowledge regarding the efficacy and safety of these procedures.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
31 Jul 2025
Start date
1 Aug 2024
Primary completion date
1 Jul 2030
Lead sponsor
Wroclaw Medical University
NCT number
NCT07109141

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 1 Aug 2024 to the primary completion date, 1 Jul 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \-

Who the study is looking for

  • Informed consent obtained from the participant
  • Subject is undergoing ablation of an atrial arrhythmia using the PFA

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Clinical Department of Cardio, Jan Mikulicz Radecki University Hospital in Wroclaw
Coordinator of this site? Confirm its status
WroclawPolandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.